End-of-life care for patients dependent on implanted life-sustaining technology presents one of modern medicine's most complex intersections of ethics, logistics, and patient autonomy. As left ventricular assist devices (LVADs) extend survival in advanced heart failure — now numbering in the tens of thousands of active recipients in the United States — the question of how and where patients can die on their own terms has become an urgent clinical frontier.
This case report from Cureus documents a 76-year-old man with end-stage heart failure who elected medical aid in dying (MAID) while dependent on an implanted LVAD. The central challenge: LVAD deactivation typically occurs in a hospital setting under intravenous sedation, because pump withdrawal triggers abrupt hemodynamic collapse and acute symptomatic heart failure. This patient's firm preference was to die at home on a chosen date. An interdisciplinary team — including an end-of-life care navigator — successfully coordinated LVAD withdrawal simultaneously with MAID medication administration in a home environment, achieving the patient's stated goals without reported ethical or legal violations.
This case sits at a genuine clinical frontier that existing LVAD deactivation protocols have not systematically addressed. The broader LVAD literature increasingly acknowledges device deactivation as ethically equivalent to withdrawing other forms of life support, a position affirmed by major cardiology and palliative care societies. However, the simultaneous coordination with MAID — legal in a growing number of U.S. states — introduces new procedural complexity requiring careful sequencing of medications, symptom management, and legal documentation across multiple care domains. As a single case report, this account cannot establish generalizable protocols, and institutional policies, state MAID statutes, and device manufacturer guidance vary considerably. What it does establish is proof of concept: patient-centered home death for LVAD-dependent individuals pursuing MAID is logistically feasible when supported by expert interdisciplinary coordination. For palliative care clinicians and cardiologists, this represents a meaningful, if early-stage, contribution to an underexplored area of end-of-life care planning.
